Results

Total Results: 1,540 records

Showing results for "month".

41. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - B 1 month VAS at rest: 2.41 (2.61) vs. 2.44 (2.14), p=NR VAS during activities of daily living: 3.62 … B 1 month change from baseline (ITT analysis, n=30 and 29) RMDQ: 3.0 (3.0) vs. 1.4 (3.4), p=0.06 ODI: … C Immediately post-intervention (18 month intervention) WOMAC-function: 17.8 (15.9 to 19.7) vs. 16.4 … C Immediately post-intervention (18 month intervention) WOMAC-function: 14.9 (13.0 to 16.8) vs. 16.4 … followup to a 6 month intervention) NR NR A vs.

42. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - B 1 month VAS at rest: 2.41 (2.61) vs. 2.44 (2.14), p=NR VAS during activities of daily living: 3.62 … B 1 month change from baseline (ITT analysis, n=30 and 29) RMDQ: 3.0 (3.0) vs. 1.4 (3.4), p=0.06 ODI: … C Immediately post-intervention (18 month intervention) WOMAC-function: 17.8 (15.9 to 19.7) vs. 16.4 … C Immediately post-intervention (18 month intervention) WOMAC-function: 14.9 (13.0 to 16.8) vs. 16.4 … followup to a 6 month intervention) NR NR A vs.

43. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.xlsx
    January 01, 2011 - FFS Cohort Population (Millions), 2006-2008 By Age Category, Gender, and Race (Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month

44. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - B 1 month VAS at rest: 2.41 (2.61) vs. 2.44 (2.14), p=NR VAS during activities of daily living: 3.62 … B 1 month change from baseline (ITT analysis, n=30 and 29) RMDQ: 3.0 (3.0) vs. 1.4 (3.4), p=0.06 ODI: … C Immediately post-intervention (18 month intervention) WOMAC-function: 17.8 (15.9 to 19.7) vs. 16.4 … C Immediately post-intervention (18 month intervention) WOMAC-function: 14.9 (13.0 to 16.8) vs. 16.4 … followup to a 6 month intervention) NR NR A vs.

45. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … least 3 months NR 433 a) 55 b) 65 c) 313 A: Daily or weekly use of marijuana B: Monthly or 1-2 times a month … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

46. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … least 3 months NR 433 a) 55 b) 65 c) 313 A: Daily or weekly use of marijuana B: Monthly or 1-2 times a month … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

47. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - beneficiary was included in the enroll- ment population for a given year if he or she had at least a 12-month … 250.20-23, 250.30-33, 250.40-43, 250.50-53, 250.60-63, 250.70-73, 250.80-83, 250.90-93) in the 12-month … determined to have diabetes if he or she had two or more ICD-9 codes consistent with diabetes in the 12-month … with diabetes or at least one inpatient claim with ICD-9 codes consistent with diabetes in the 12-month … (For Algorthim 4, the 12-month period required continuous enrollment in Part D as well as Parts A and

48. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.xlsx
    January 01, 2011 - Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) (Algorithm 3: 12-month … B Fee-for-Service Beneficiaries, 2006-2008 By Age Category, Gender, and Race (Algorithm 3: 12-month … B Fee-for-Service Beneficiaries, 2006-2008 By Age Category, Gender, and Race (Algorithm 3: 12-month … and B Fee-for-Service Beneficiaries, 2006-2008 By Age Category, Gender, and Race (Algorithm 3: 12-month

49. Executive Summary: Comparative Effectiveness Review No. 256_Effectiveness of Telehealth for Women's Preventive Services (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
    June 01, 2022 - Contraception Contraceptive use Supplemental telephone counseling; Structured telephone support 4-month … Low STI rates Supplemental telephone counseling 4-month supply of OCPs, condoms, and in-person … Low Pregnancy rates Supplemental telephone counseling 4-month supply of OCPs, condoms, and in-person

50. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - note that beneficiaries were considered continuously enrolled for 12 months, centered on a given month … , if they were alive in that given month and were continuously en- rolled up until death. … For this purpose, beneficiaries were considered alive up to and including the month of their death … 250.20-23, 250.30-33, 250.40-43, 250.50-53, 250.60-63, 250.70-73, 250.80-83, 250.90-93) in the 12-month … 730.16, 730.19,730.26-29, 891.0, 891.1,891.2, 892.0, 892.1, 892.2), but had at least a preceding 6-month

51. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The wholesale cost was reported as $2,055 per month for 30 tablets, or about $25,000 annually, a cost … (n=12) and 12-month (n=10) followup. … at baseline (p<0.0005). 25 By 24-month followup, all evaluated outcomes were significantly lower … than those observed at 12-month followup. … group than placebo group; at month 6, higher percentages of patients given active treatment had a

52. Amended Protocol: Management of Infantile Epilepsy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
    March 07, 2021 - important evidence gaps, this systematic review will focus on treatment of epilepsy in children age 1 month … This systematic review aims to identify studies addressing management of epilepsy for children 1 month … Intervention, Comparator, Outcome, Timing, Setting) Inclusion Exclusion Population • Infants (1 month … At enrollment, infants (age 1 month to <3 years) must have a diagnosis of epilepsy. … patients, we require either that 1) studies enroll a population for which at least 80% were age 1 month

53. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - One was a small 6-month study (n=15) that randomized inmates to be offered the first monthly dose of … FDA for the treatment of OUD are a 1-month buprenorphine injection, a 6-month buprenorphine implant, … and a 1-month naltrexone injection. … Only required to attend 1 counseling session/month. … Only required to attend 1 counseling session/month.

54. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Fee-for-Service (FFS) Cohort Population (Millions), 2006-2008, by Age, Gender, and Race Algorithm 3: 12-month … 2008, by Age, Gender, and Race, and by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month … A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race Algorithm 3: 12-month

55. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month … Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month … A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race Algorithm 3: 12-month … A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race Algorithm 3: 12-month … A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race Algorithm 3: 12-month

56. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - vs 6 month withdrawal of MTX did not reduce the relapse rate. … Abatacept in the treatment of patients with psoriatic arthritis: results of a six- month, multicenter … In period A, 2.6 days /month and 2.3 parents; usual activity days/month were gained. … group relapsed within 24 months, while 94/181 (55.6%) of the 12 month group did. … Active arthritis persisted at 1 month in 39%, at 3 months in 27%, at > 6 months in 11%.

57. Juvenile-Arthritis-Dmards Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - vs 6 month withdrawal of MTX did not reduce the relapse rate. … Abatacept in the treatment of patients with psoriatic arthritis: results of a six- month, multicenter … In period A, 2.6 days /month and 2.3 parents; usual activity days/month were gained. … group relapsed within 24 months, while 94/181 (55.6%) of the 12 month group did. … Active arthritis persisted at 1 month in 39%, at 3 months in 27%, at > 6 months in 11%.

58. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - were hospitalized with aspiration pneumonia or aspiration pneumonitis at any time following the six month … Prescriptions for chronically administered medications in the UK are issued in one-month increments. … prior six months (mean 0.72 vs. 0.13), and number of non- antidepressant prescriptions in the prior month … six months 2.8 (3.1) 0.8 (1.6) mean (SD) number of non-antidepressant prescriptions in prior month … months 3.16 (3.03) 0.84 (1.65) mean (SD) number of non-antidepressant prescriptions in prior month

59. Arcia-notes-Teresa (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
    May 29, 2025 - In   this version, we removed   the month  designation  and  we made it cleaner, more open …   five days noted  on   the calendar, people would  say, "Oh  yes, it's that time of the month … " or "Oh  yes, she was depressed   from the first S unday through   the first Thursday of the month … Then  we have a field-­‐test  of about   one month  where we will give them a mobile hotspot … F inally, we'll bring them back a month   later and  gather standardized metrics of usability and

60. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in AdultsBrain Injury in Adults Surveillance Report 08082016 CCKK CC final clean (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    May 29, 2025 - $One$study$found$no$difference$between$groups$at$6$month$ follow"up.$$ •$ CIQ$Post$Treatment$(1$RCT … $Life$(QoL)$(1$RCT):$SOE$NR$ o$ There$was$no$difference$between$groups$post"treatment,$nor$at$6$ month … $follow" up$and$at$12"month$follow"up. … $One$study$found$no$ difference$between$groups$at$6$ month$follow"up.$$ •$ CIQ$Post$Treatment$(1$ … $ follow"up$and$at$12"month$ follow"up.